Stanford Medicine
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Stanford Medicine
Jun 25, 2024, 08:30 |
Blog
2024 ASH Honorific Award recipients
ASH shared on X: "A huge ASH Kudos to the 2024 ASH Honorific Award recipients! This…
Jun 17, 2024, 16:14 |
Blog
Lorenz Mayr: The benefits of CAR-T therapy largely outweigh the potential risks of the CAR-T technology
Lorenz Mayr, CEO at Mayr BioMedTech Consulting, shared on LinkedIn: "Secondary Cancer Risk Is Low…
May 12, 2024, 02:55 |
Career
Justin Baker: Such a tremendous blessing to be named a 2024 AAHPM Visionary in Hospice and Palliative Medicine!
Justin Baker, Chief, Division of Quality of Life and Pediatric Palliative Care at Stanford Medicine,…
May 7, 2024, 04:10 |
Blog
Carolyn Rodríguez: What a joy to see Stanford trainees shine presenting their research
Carolyn Rodríguez, Professor and Associate Dean at Stanford Medicine, shared a post on X: "What a…
Apr 15, 2024, 21:37 |
Blog
Cristiane Bergerot: I made the list of top reviewers in 2022 at JCO Journals
Cristiane Bergerot shared a post by Kekoa Taparra, Resident Physician and Post-Doctoral Medical Fellow at…
Mar 9, 2024, 13:08 |
Blog
Justin Baker: Such a blast to be advocating for the precious Pediatric Palliative Care kiddos and their families!
Justin Baker, Chief, Division of Quality of Life and Pediatric Palliative Care at Stanford Medicine,…
Jul 26, 2023, 20:18 |
Societies
New Stanford Medicine podcast: Health After Cancer
In a post by Stanford CME on Twitter, it says, "New Stanford Medicine podcast: Health…
All:
7
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube